Dr. Thomas So Talks Diabetes & Obesity Drugs, Clinical Trials
Thomas So, PharmD, a clinical pharmacist and Sr. Manager of Consumer Drug Information Group at FDB (First Databank), discusses diabetes and obesity drugs currently on the market and related clinical research.
Native Hawaiian and Pacific Islander Adults Suffer Second Highest Cardiovascular Death Rate in the US
Lower Overall Reponse Rates to Idecabtagene Vicleucel in Hispanic Patients With Multiple Myeloma
Advanced Age, Financial Constraints Contribute to Higher Ibrutinib Discontinuation Rates in Medicare Recipients